Literature DB >> 2208948

Acute effects of 3'-azido-3'-deoxythymidine on the cell cycle of HL60 cells.

M Roskrow1, S N Wickramasinghe.   

Abstract

The average doubling times of HL60 cells grown in the presence of 0,5,10 and 100 microM 3'-azido-3'-deoxythymidine (AZT) for 72 h were, respectively, 51.1, 65.7, 69.0 and 76.3 h. This drug-concentration-dependent prolongation of the cell-doubling time was associated with a progressive increase in modal cell volume. The technique of combined Feulgen microspectrophotometry and 3H-thymidine autoradiography revealed that the cell cycle distribution of HL60 cells cultured in the presence of 5 and 100 microM AZT for 48 h was abnormal, with an increased percentage of cells in the S phase and a decreased percentage in the G1phase. From the cell doubling times and the cell cycle distribution data, and making a number of assumptions, upper limit estimates for the duration of the S phase in cultures containing 0,5 and 100 microM AZT were calculated to be 26.2, 35.8 and 49.6 h, respectively. The data indicate that concentrations of AZT achieved in the plasma of patients receiving this drug (i.e. 5 microM) cause a substantial prolongation of both the cell cycle time and the duration of the S phase of HL60 cells. It therefore seems likely that some of the toxic effects of AZT seen in vivo, including impairment of bone marrow function, are at least partly related to AZT-induced disturbances of DNA synthesis and proliferation in human cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208948

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  7 in total

1.  Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine.

Authors:  Jia-Long Fang; Tao Han; Qiangen Wu; Frederick A Beland; Ching-Wei Chang; Lei Guo; James C Fuscoe
Journal:  Arch Toxicol       Date:  2013-11-30       Impact factor: 5.153

2.  Synergy between 3'-azido-3'-deoxythymidine and paclitaxel in human pharynx FaDu cells.

Authors:  Jeffrey S Johnston; Andrew Johnson; Yuebo Gan; M Guillaume Wientjes; Jessie L S Au
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

3.  Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion.

Authors:  Metodi V Stankov; Reinhold E Schmidt; Georg M N Behrens
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

4.  Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells.

Authors:  Jia-Long Fang; Lynda J McGarrity; Frederick A Beland
Journal:  Mutagenesis       Date:  2008-10-20       Impact factor: 3.000

5.  Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes.

Authors:  Jia-Long Fang; Frederick A Beland
Journal:  Toxicol Sci       Date:  2009-06-18       Impact factor: 4.849

6.  Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells.

Authors:  Ofelia A Olivero; Irma L Vazquez; Catherine C Cooch; Jessica Ming; Emily Keller; Mia Yu; Jennifer P Borojerdi; Hannan M Braun; Edward McKee; Miriam C Poirier
Journal:  Toxicol Sci       Date:  2010-01-27       Impact factor: 4.849

7.  Role of DNA Repair Pathways in Response to Zidovudine-induced DNA Damage in Immortalized Human Liver THLE2 Cells.

Authors:  Qiangen Wu; Frederick A Beland; Ching-Wei Chang; Jia-Long Fang
Journal:  Int J Biomed Sci       Date:  2013-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.